APA (7th ed.) Citation

LM, M., AAAA, M., JM, S., MF, Y., LA, R., & HI, A. (2024). Interleukin 1β receptor blocker (Anakinra) and regenerative stem cell therapy: Two novel approaches effectively ameliorating diabetic cardiomyopathy. Naunyn-Schmiedeberg's archives of pharmacology, 397(10), 8023. https://doi.org/10.1007/s00210-024-03152-1

Chicago Style (17th ed.) Citation

LM, Mahmoud, Mageed AAAA, Saadallah JM, Youssef MF, Rashed LA, and Ammar HI. "Interleukin 1β Receptor Blocker (Anakinra) and Regenerative Stem Cell Therapy: Two Novel Approaches Effectively Ameliorating Diabetic Cardiomyopathy." Naunyn-Schmiedeberg's Archives of Pharmacology 397, no. 10 (2024): 8023. https://doi.org/10.1007/s00210-024-03152-1.

MLA (9th ed.) Citation

LM, Mahmoud, et al. "Interleukin 1β Receptor Blocker (Anakinra) and Regenerative Stem Cell Therapy: Two Novel Approaches Effectively Ameliorating Diabetic Cardiomyopathy." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 397, no. 10, 2024, p. 8023, https://doi.org/10.1007/s00210-024-03152-1.